CURE Talks Cancer

Before listening to this podcast, please note that it contains a personal account of 9/11 terrorist attacks in New York City that may be unsettling or triggering. Listener discretion is advised. 
On Sept. 11, 2001, Judy Meyers was on a train into New York City where she worked as a commercial real estate paralegal. While the day started like many others, the terrorist attacks on the World Trade Center made that fateful Tuesday one of the deadliest days in American history. 
While Meyers was able to miss being at the site of the attacks – which she credited to luck and timing – she was soon back at work in lower Manhattan, breathing in air that she said smelled horrible but was reportedly safe. Years later in 2019, she was diagnosed with stage 3b non-small cell adenocarcinoma that was linked to her exposure following the 9/11 attacks. 
In this special edition episode of the “CURE® Talks Cancer” podcast, Meyers shares her story.  

In this special edition, CURE spoke with Dr. Laura Michaelis, a specialist in hematology and oncology at Froedtert Hospital and Medical College of Wisconsin in Milwaukee and also a recipient of the 2019 MPN Heroes Award. 
Michaelis has a mission statement to live up to when she’s treating patients: “deliver superb care in a compassionate, individualized manner.” As an MPN Hero, Michaelis has gone above and beyond to offer outstanding healthcare in and outside of the clinic, regularly speaking to MPN patient support groups to provide important information and answers in a more personal setting. 
She spoke with CURE about how far we’ve come in the MPN space, how we can address current challenges moving forward, and what being an MPN Hero means to her.
CURE® is now accepting nominations for its ninth annual MPN Heroes Awards! CURE and Inctye are proud to honor heroes who have made a significant impact in the lives of those affected by MPNs. For more information or to nominate your hero today, visit, www.curetoday.com/award-events.

In this special edition, CURE spoke with Rose Gerber, Director of Patient Advocacy & Education at the Community Oncology Alliance and a breast cancer survivor, about disparities in cancer care, and what we can do to address them moving forward.
CURE® is now accepting nominations for our inaugural Metastatic Breast Cancer Heroes™ Awards! For our inaugural celebration, we are proud to present two separate awards honoring heroes who have made a significant impact in the lives of those affected by metastatic breast cancer. For more information or to nominate your hero today, visit, https://www.curetoday.com/award-events.

In this episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Naveen Pemmaraju, associate professor of Leukemia at The University of Texas MD Anderson Cancer Center, who recently conducted research on disease awareness in patients with myeloproliferative neoplasms (MPNs). 
Many patients with MPNs reported going to the internet to seek out information about their disease; however, many still did not know about some of the common markers of their disease. While the internet can be a great source of information, there is plenty of misinformation available, too, so it is always important that patients take what they find online and talk to their providers about it. 

Read more: https://www.curetoday.com/view/how-to-find-reliable-cancer-information-online